When the GLP-1 and GIP responses during the OGTT were regressed against the incretin effect on total insulin secretion (Figure 6), the relationship was significantly flatter in patients with T2D than subjects with NGT for both incretin hormones, as expected. The gene discussed is GIP; the disease is type 2 diabetes mellitus.